Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

From magic mountain to table mountain.

Diacon AH, von Groote-Bidlingmaier F, Donald PR.

Swiss Med Wkly. 2012 Aug 22;142:w13665. doi: 10.4414/smw.2012.13665. Review.

2.

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID:
14621568
3.

Recent developments in the treatment of tuberculosis.

Davies PD, Yew WW.

Expert Opin Investig Drugs. 2003 Aug;12(8):1297-312. Review.

PMID:
12882618
4.

[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].

Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R.

Schweiz Med Wochenschr. 1989 Mar 11;119(10):299-305. German.

PMID:
2652281
6.

Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.

Shah AR, Agarwal SK, Shah KV.

Int J Tuberc Lung Dis. 2002 Dec;6(12):1098-101.

PMID:
12546118
7.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
8.

[Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].

de Kantor IN, Latini O, Barrera L.

Medicina (B Aires). 1998;58(2):202-8. Spanish.

PMID:
9706257
9.

Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis.

Nagaraja C, Shashibhushan BL, Asif M, Manjunath PH, Sagar C.

Indian J Chest Dis Allied Sci. 2012 Jan-Mar;54(1):23-6.

PMID:
22779119
10.

Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.

Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.

East Afr Med J. 1999 Jun;76(6):307-13.

PMID:
10750516
11.

[Anti-tuberculosis chemotherapy].

Wada M.

Kekkaku. 2007 Oct;82(10):771-81. Review. Japanese.

PMID:
18018601
12.

The chemotherapy of tuberculous meningitis in children and adults.

Donald PR.

Tuberculosis (Edinb). 2010 Nov;90(6):375-92. doi: 10.1016/j.tube.2010.07.003. Review.

PMID:
20810322
13.
14.

[Antitubercular chemotherapy].

Jouveshomme S, Dautzenberg B.

Rev Mal Respir. 1997 Dec;14 Suppl 5:S88-104. Review. French.

PMID:
9496594
15.

Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.

Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE.

Int J Tuberc Lung Dis. 2000 Feb;4(2):108-14.

PMID:
10694087
16.

Drug resistance in tuberculosis patients in Jodhpur district.

Mathur ML, Khatri PK, Base CS.

Indian J Med Sci. 2000 Feb;54(2):55-8.

17.

The resumption of consumption -- a review on tuberculosis.

Ducati RG, Ruffino-Netto A, Basso LA, Santos DS.

Mem Inst Oswaldo Cruz. 2006 Nov;101(7):697-714. Review.

18.

Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.

Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.

Int J Tuberc Lung Dis. 2002 Dec;6(12):1102-9.

PMID:
12546119
19.

The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis.

Seung KJ, Gelmanova IE, Peremitin GG, Golubchikova VT, Pavlova VE, Sirotkina OB, Yanova GV, Strelis AK.

Clin Infect Dis. 2004 Nov 1;39(9):1321-8.

20.
Items per page

Supplemental Content

Support Center